NEUP

$2.731.36%-0.0377

Neuphoria Therapeutics Inc (NEUP)

Neuphoria Therapeutics Inc Stock (NEUP) Forecast

The Neuphoria Therapeutics Inc (NEUP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.37, representing a +169.82% increase from the current price of $2.73. The highest analyst price target is $12.10, and the lowest is $2.64.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month NEUP Price Target

Average 11.81 (+332.19% Upside)

Is Neuphoria Therapeutics Inc (NEUP) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	16.59	Buy
STOCH(9,6)	4.11	Buy
STOCHRSI(14)	7.98	Buy
MACD(12,26)	-0.18	Sell
ADX(14)	30.30	Sell
William %R	-96.37	Buy
CCI(14)	-167.73	Sell

Buy: 4 · Sell: 3 · Neutral: 0Summary: Buy

Moving Averages

Period	Simple	Exponential
MA10	3.08 Sell	3.02 Sell
MA20	3.22 Sell	3.17 Sell
MA50	3.48 Sell	3.42 Sell
MA100	3.66 Sell	3.71 Sell
MA200	4.13 Sell	4.53 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, NEUP could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on NEUP, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 16.59 indicates that NEUP is oversold. This indicates that NEUP price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
STOCH (Stochastic Oscillator): The STOCH value of 4.11 indicates that NEUP is oversold. This indicates that NEUP price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.98 indicates that NEUP is oversold. This suggests that NEUP price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 30.30 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -167.73 indicates that NEUP is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term NEUP price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Neuphoria Therapeutics Inc financial reports and earnings history, Neuphoria Therapeutics Inc (NEUP) stock could reach $4.72 by 2030, $18.42 by 2040 and $16.30 by 2050. See the projected annual prices until 2050 of the Neuphoria Therapeutics Inc stock below:

Neuphoria Therapeutics Inc (NEUP) is expected to reach an average price of $10.87 in 2035, with a high prediction of $13.00 and a low estimate of $0.6527. This indicates an +297.87% change from the last recorded price of $2.73.
Neuphoria Therapeutics Inc (NEUP) stock is projected to chart a bullish course in 2040, with an average price target of $1.54, representing an -43.69% change from its current level. The forecast ranges from a conservative $0.7149 to a sky-high $18.42.
Our analysts predict Neuphoria Therapeutics Inc (NEUP) to change -73.24% by 2045, soaring from $0.00153 to an average price of $0.7313, potentially reaching $8.07. While $0.00153 is the low estimate, the potential upside is significant.
Neuphoria Therapeutics Inc (NEUP) stock is expected to climb by 2050, reaching an average of $0.82, a -69.99% change from its current level. However, a wide range of estimates exists, with high and low targets of $16.30 and $0.0101, respectively, highlighting the market's uncertainty.

Neuphoria Therapeutics Inc Stock (NEUP) Year by Year Forecast

Neuphoria Therapeutics Inc Stock (NEUP) Price Forecast for 2026

The predicted value for Neuphoria Therapeutics Inc (NEUP) in 2026 is set at an average of $4.05. Estimates vary from a peak of $12.10 to a trough of $2.45, indicating an +48.33% surge from the present price of $2.73.

Month	Average	Low	High	Change from today's price
December, 2026	$4.49	$2.64	$12.10	+64.47%

Neuphoria Therapeutics Inc Stock (NEUP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Neuphoria Therapeutics Inc (NEUP) is $6.64, with a high forecast of $20.98 and a low forecast of $3.23. This indicates an +143.09% increase from the last price of $2.73.

Month	Average	Low	High	Change from today's price
January, 2027	$4.28	$3.89	$5.32	+56.50%
February, 2027	$4.72	$4.27	$5.68	+72.68%
March, 2027	$4.62	$4.07	$4.97	+68.94%
April, 2027	$6.21	$4.16	$6.72	+127.21%
May, 2027	$6.67	$5.56	$7.23	+143.96%
June, 2027	$8.07	$6.42	$8.30	+195.28%
July, 2027	$7.67	$6.51	$8.47	+180.72%
August, 2027	$9.67	$6.39	$14.71	+253.83%
September, 2027	$17.07	$9.09	$20.98	+524.93%
October, 2027	$3.68	$3.33	$17.97	+34.58%
November, 2027	$3.66	$3.53	$4.76	+33.95%
December, 2027	$3.40	$3.23	$3.73	+24.51%

Neuphoria Therapeutics Inc Stock (NEUP) Price Forecast for 2028

In 2028, Neuphoria Therapeutics Inc (NEUP) is projected to reach an average price of $3.56, with a high projection of $5.12 and a low estimate of $2.00. This indicates an +30.13% rise from the last price of $2.73.

Month	Average	Low	High	Change from today's price
January, 2028	$3.59	$3.39	$4.01	+31.56%
February, 2028	$3.91	$3.53	$4.53	+42.99%
March, 2028	$3.66	$3.43	$4.46	+33.92%
April, 2028	$4.63	$3.66	$4.70	+69.50%
May, 2028	$5.07	$4.00	$5.12	+85.70%
June, 2028	$3.91	$3.55	$5.12	+42.96%
July, 2028	$3.01	$2.79	$4.24	+10.30%
August, 2028	$3.47	$2.88	$3.80	+27.03%
September, 2028	$3.37	$3.31	$3.94	+23.45%
October, 2028	$3.08	$3.06	$3.47	+12.57%
November, 2028	$2.66	$2.64	$3.20	-2.72%
December, 2028	$2.30	$2.00	$3.05	-15.74%

Neuphoria Therapeutics Inc Stock (NEUP) Price Forecast for 2029

The 2029 price forecast for Neuphoria Therapeutics Inc Stock (NEUP) is $6.53 on average, with a high prediction of $20.55 and a low estimate of $2.10. This represents an +139.14% increase from the previous price of $2.73.

Month	Average	Low	High	Change from today's price
January, 2029	$4.05	$2.10	$11.65	+48.14%
February, 2029	$3.83	$3.44	$4.88	+40.25%
March, 2029	$4.28	$3.82	$5.24	+56.51%
April, 2029	$4.18	$3.63	$4.53	+52.86%
May, 2029	$5.77	$3.72	$6.29	+111.21%
June, 2029	$6.13	$5.12	$6.80	+124.37%
July, 2029	$7.64	$5.93	$7.87	+179.46%
August, 2029	$7.24	$6.08	$8.04	+164.98%
September, 2029	$12.15	$5.96	$14.28	+344.84%
October, 2029	$16.65	$8.43	$20.55	+509.37%
November, 2029	$3.25	$2.90	$17.54	+19.10%
December, 2029	$3.24	$3.11	$4.34	+18.57%

Neuphoria Therapeutics Inc Stock (NEUP) Price Forecast for 2030

Neuphoria Therapeutics Inc Stock (NEUP) is expected to reach an average price of $3.18 in 2030, with a high forecast of $4.72 and a low forecast of $2.25. This signifies an +16.52% surge from the last price of $2.73.

Month	Average	Low	High	Change from today's price
January, 2030	$2.98	$2.81	$3.31	+9.21%
February, 2030	$3.19	$2.97	$3.59	+16.69%
March, 2030	$3.32	$3.11	$3.67	+21.60%
April, 2030	$3.25	$3.02	$4.11	+18.87%
May, 2030	$4.22	$3.25	$4.29	+54.53%
June, 2030	$3.92	$3.85	$4.64	+43.35%
July, 2030	$3.50	$3.14	$4.72	+28.17%
August, 2030	$2.74	$2.39	$3.84	+0.15%
September, 2030	$3.07	$2.48	$3.40	+12.43%
October, 2030	$2.98	$2.91	$3.54	+8.93%
November, 2030	$2.77	$2.74	$3.07	+1.40%
December, 2030	$2.27	$2.25	$2.80	-17.07%

Similar to NEUP